Mr Daniel Wolf > Kirkland & Ellis LLP > New York, United States > Lawyer Profile

Kirkland & Ellis LLP
601 LEXINGTON AVENUE
NEW YORK, NY 10022
United States
Daniel Wolf photo

Work Department

Corporate

Position

Daniel focuses on mergers and acquisitions, representing public and private companies and private equity firms in a variety of domestic and international transactions. His transactional experience spans the range of M&A activity, including many significant cross-border and contested transactions, as well as representing boards of directors in activism defense and governance matters. Clients he has represented include Bristol-Myers Squibb, Blackstone Group, Vista Equity Partners, Avis Budget, Teva Pharmaceutical, GrubHub, Ventas, Akzo Nobel and GSK.

Languages

Hebrew

Education

London School of Economics and Political Science, United Kingdom, LLB, 1995, first class honours.

Lawyer Rankings

United States > Real estate > Real estate investment trusts (REITs)

Kirkland & Ellis LLP has experience of REIT-related M&A and corporate governance matters. It regularly supports clients and their board of directors on matters including shareholder activism, takeover readiness, fiduciary duty and disclosure issues. New York-based Daniel Wolf and David Fox are contacts in the team.

United States > M&A/corporate and commercial > Shareholder activism

Spread across the firm’s New York, San Francisco, and Houston offices, the team at Kirkland & Ellis LLP is experienced at aiding boards in defending against shareholder activism, particularly activism related to M&A transactions. A key part of the firm’s comprehensive corporate offering, the lawyers focusing on activism defense have broad expertise in all things corporate law, including transactional M&A and private equity deals, and strategic governance and advisory work. In a high-profile case in 2019, the firm advised Bristol-Myers Squibb on activism related to its proposed acquisition of Celgene Corporation, in which opposition to the deal came both from Starboard Value and institutional investor Wellington Management. Key contacts in the New York office include Sarkis Jebejian, Eric Schiele, and Shaun Mathew, David Fox, and Daniel Wolf. The Houston team in particular is a go-to advisor for energy companies facing threats of activist actions; the contact here is Sean Wheeler.

United States > M&A/corporate and commercial > M&A: large deals ($1bn+)

(Hall of Fame)

Daniel WolfKirkland & Ellis LLP

Kirkland & Ellis LLP has a broad transactional practice, acting as lead counsel in public M&A, large-scale and cross-border joint ventures, and contested transactions. Clients of note include Bristol Myers-Squibb, GlaxoSmithKline, and General Motors. Bristol Myers-Squibb in particular provided a key mandate for the practice in the form of its $90bn acquisition of Celgene, a significant transaction within the pharmaceuticals sector led by established ‘outstanding practitionersDaniel Wolf, David Fox, and Jonathan Davis. The team is also active in transactions in the logistics, healthcare, shipping, and manufacturing industries. The firm’s US-wide platform is aided further by strong global connectivity with offices in Europe, Africa, South America, and Asia, enabling it to access ‘great expertise’ from a variety of sources in complex cross-border transactions. The ‘exceptionalEric Schiele is also highly recommended by clients, while Houston-based David Castro and Christopher Heasley are noted for their work in energy sector transactions. All lawyers are in New York unless otherwise stated.